Yolk sac tumor of postpubertal-type does not exhibit immunohistochemical loss of SMARCB1/INI1 and SMARCA4/BRG1 ... but choriocarcinoma? ...

被引:0
|
作者
Ricci, Costantino [1 ,2 ]
Ambrosi, Francesca [1 ,2 ]
Franceschini, Tania [1 ]
Giunchi, Francesca [3 ]
Franchini, Eugenia [1 ]
Massari, Francesco [2 ,4 ]
Mollica, Veronica [2 ,4 ]
Bianchi, Federico Mineo [5 ]
Colecchia, Maurizio [6 ]
Acosta, Andres Martin [7 ]
Fiorentino, Michelangelo [1 ,2 ,8 ]
机构
[1] Maggiore Hosp AUSL Bologna, Pathol Unit, Bologna, Italy
[2] Univ Bologna, Dept Expt Diagnost & Specialty Med DIMES, Bologna, Italy
[3] IRCCS Azienda Osped Univ Bologna, Pathol Unit, Bologna, Italy
[4] IRCCS Azienda Osped Univ Bologna, Med Oncol, Bologna, Italy
[5] Maggiore Hosp AUSL Bologna, Urol Dept, Bologna, Italy
[6] IRCCS San Raffaele Sci Inst, Dept Pathol, Milan, Italy
[7] Harvard Med Sch, Brigham & Womens Hosp, Dept Pathol, Boston, MA USA
[8] Univ Bologna Bologna, Dept Expt Diagnost & Specialty Med DIMES, Via Massarenti 9, I-40138 Bologna, Italy
关键词
Germ cell tumors of the testis; Yolk sac tumor; SWI; SNF complex; SMARCB1; INI1; SMARCA4; BRG1; GERM-CELL TUMORS; UNDIFFERENTIATED CARCINOMA; MOLECULAR CHARACTERIZATION; SINONASAL CARCINOMA; EXPRESSION; DIFFERENTIATION; INI1;
D O I
10.1016/j.prp.2022.154269
中图分类号
R36 [病理学];
学科分类号
100104 ;
摘要
The recently described SWI/SNF complex-deficient sinonasal carcinoma (SMARCB1 & SMARCA4) may exhibit a yolk sac-like morphology. Tumors with similar features (yolk sac-like histology combined with the immuno-histochemical loss of SMARCB1/INI1 and/or SMARCA4/BRG1) have also been described in other sites, such as the female genital tract. In this study, we immunohistochemically assessed SMARCB1/INI1 and SMARCA4/BRG1 expression to evaluate if these proteins could be involved in the pathogenesis of testicular yolk sac tumors of postpubertal type (YSTpt). Specifically, we analyzed a retrospective case series comprising pure YSTpt and mixed germ cell tumors of the testis (GCTT) with YSTpt components. In the present study, no testicular YSTpt showed loss of SMARCB1/INI1 (0/24, 0%) or SMARCA4/BRG1 (0/24, 0%). However, testicular choriocarcinoma (CHC) and isolated syncytiotrophoblast cells (iSTCs) demonstrated abnormal staining patterns for SMARCA4/BRG1 [CHC: 4/4 (100%); iSTCs: 12/12 (100%), respectively], including focal or diffuse loss of expression in a subset of cases. The results of our study suggest that functional loss of SMARCA4/BRG1 represents a recurrent event that may be relevant for the pathogenesis of a subset of testicular CHC.
引用
收藏
页数:6
相关论文
共 25 条
  • [1] Loss of the SWI/SNF-ATPase subunit members SMARCF1 (ARID1A), SMARCA2 (BRM), SMARCA4 (BRG1) and SMARCB1 (INI1) in oesophageal adenocarcinoma
    Schallenberg, Simon
    Bork, Julian
    Essakly, Ahlem
    Alakus, Hakan
    Buettner, Reinhard
    Hillmer, Axel M.
    Bruns, Christiane
    Schroeder, Wolfgang
    Zander, Thomas
    Loeser, Heike
    Gebauer, Florian
    Quaas, Alexander
    BMC CANCER, 2020, 20 (01)
  • [2] Loss of expression of SMARCA4 (BRG1), SMARCA2 (BRM) and SMARCB1 (INI1) in undifferentiated carcinoma of the endometrium is not uncommon and is not always associated with rhabdoid morphology
    Ramalingam, Preetha
    Croce, Sabrina
    McCluggage, W. Glenn
    HISTOPATHOLOGY, 2017, 70 (03) : 359 - 366
  • [3] Pattern of SMARCB1 (INI1) and SMARCA4 (BRG1) in poorly differentiated endometrioid adenocarcinoma of the uterus: analysis of a series with emphasis on a novel SMARCA4-deficient dedifferentiated rhabdoid variant
    Strehl, Johanna D.
    Wachter, David L.
    Fiedler, Jutta
    Heimerl, Engelbert
    Beckmann, Matthias W.
    Hartmann, Arndt
    Agaimy, Abbas
    ANNALS OF DIAGNOSTIC PATHOLOGY, 2015, 19 (04) : 198 - 202
  • [4] SMARCB1 (INI1)-Deficient Sinonasal Carcinoma with Yolk Sac differentiation Showing Co-loss of SMARCA4 Immunostaining - A Case Report and Literature Review
    Ng, Joanna K. M.
    Chan, Jason Y. K.
    Li, Joshua J. X.
    Tang, Kinglam
    Yeung, David C. M.
    Chan, Amy B. W.
    HEAD & NECK PATHOLOGY, 2022, 16 (03) : 934 - 941
  • [5] Role of SMARCA4 (BRG1) and SMARCB1 (INI1) in Dedifferentiated Endometrial Carcinoma With Paradoxical Aberrant Expression of MMR in the Well-Differentiated Component: A Case Report and Review of the Literature
    Kaur, Ramandeep
    Mehta, Jay
    Borges, Anita M.
    INTERNATIONAL JOURNAL OF SURGICAL PATHOLOGY, 2021, 29 (05) : 571 - 577
  • [6] Sinonasal SMARCB1 (INI1) Deficient Carcinoma With Yolk Sac Tumor Differentiation: Report of a Case and Comparison With INI1 Expression in Gonadal Germ Cell Tumors
    Zamecnik, Michal
    Rychnovsky, Jiri
    Syrovatka, Jakub
    INTERNATIONAL JOURNAL OF SURGICAL PATHOLOGY, 2018, 26 (03) : 245 - 249
  • [7] SMARCB1 (INI1) Deficient Sinonasal Carcinoma With Yolk Sac Tumor Differentiation: Case Report and Review of the Literature
    Gradecki, Sarah E.
    Kelting, Sarah M.
    Stelow, Edward B.
    AJSP-REVIEWS AND REPORTS, 2021, 26 (04): : 259 - 263
  • [8] Sinonasal SMARCB1 (INI1) Deficient Carcinoma with Yolk Sac Tumor Differentiation: A Case Report and Treatment Options
    Burak Hazir
    Berkay Şímșek
    Arzu Erdemír
    Fatih Gürler
    Ozan Yazici
    Yusuf Kizil
    Utku Aydíl
    Head and Neck Pathology, 2022, 16 : 596 - 601
  • [9] Sinonasal SMARCB1 (INI1) Deficient Carcinoma with Yolk Sac Tumor Differentiation: A Case Report and Treatment Options
    Hazir, Burak
    Simsek, Berkay
    Erdemir, Arzu
    Gurler, Fatih
    Yazici, Ozan
    Kizil, Yusuf
    Aydil, Utku
    HEAD & NECK PATHOLOGY, 2022, 16 (02) : 596 - 601
  • [10] SMARCB1/INI1 Loss in Epithelioid Schwannoma: A Clinicopathologic and Immunohistochemical Study of 65 Cases
    Jo, Vickie Y.
    Fletcher, Christopher D. M.
    AMERICAN JOURNAL OF SURGICAL PATHOLOGY, 2017, 41 (08) : 1013 - 1022